The challenge of detecting alpha-1 antitrypsin deficiency

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue S1, 2013, Pages 26-34

  Stoller, James K ^a   Brantly, Mark ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Case finding; Detection; Screening; Targeted detection

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CASE FINDING; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC KIT; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; HEALTH CARE PLANNING; HUMAN; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; GENETIC TESTING; GUIDELINE ADHERENCE; HUMANS; MASS SCREENING; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE;

EID: 84875675170     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.763782     Document Type: Review

References (74)

1. Stoller JK, Snider GL (co-chairmen), Brantly ML, et al. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and management of patients with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:816-900 and Respir Care 2003; 48:1043-1047.
2. Stoller JK, Aboussouan L. Concise clinical review: Alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2012; 185:246-259.
3. Silverman EK. Sandhaus RA. Clinical Practice: Alpha-1 antitrypsin deficiency. New Engl J Med 2009; 360(26):2749- 2757.
4. Aboussouan LS, Stoller JK. Detection of alpha-1 antitrypsin deficiency: A review. Respir Med 2009; 103:335-341.
5. Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha-1 antitrypsin deficiency: Results of a survey. Cleve Clin J Med 1994; 61:461-467.
6. Stoller JK, Sandhaus RA, Turino G, Dickson R, et al. Delay in diagnosis of alpha-1 antitrypsin deficiency: A continuing problem. Chest 2005; 128:1989-1994.
7. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha-1 antitrypsin deficiency between 1968 and 2003. Chest 2005; 128:1179-1186.
8. Laurell C-B, Eriksson A. The electrophoretic alpha-1 globulin pattern of serum in alpha-1 antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132-140.
9. O'Brien ML, Buist NRM, Murphey WH. Neonatal screening for alpha-1 antitrypsin deficiency. J Pediatrics 1978; 92(6):1006- 1010.
10. Sveger T. Liver disease in alpha-1 antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med1976; 294:1316-1321.
11. Mayer A, Stoller JK, Bartelson BB, et al. Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis 2006; 4:485-492.
12. Ranes J, Stoller JK. A review of alpha-1 antitrypsin deficiency. Sem Respir Crit Care Med 2005; 26:154-166.
13. Mohanka M, Khemasuwan D, Stoller JK. A review of augmentation therapy for alpha-1 antitrypsin deficiency. Expert Opin Biol Ther 2012 Jun; 12(6):685-700.
14. Tanash HA, Nilsson PM, Nilsson JA, Piitulainen E. Thorax 2008; 63:1091-1095.
15. Luisetti M, Seersholm N. Alpha-1 antitrypsin deficiency. 1: Epidemiology of alpha-1 antitrypsin deficiency. Thorax 2004; 59:164-169.
16. Tobin MJ, Cook PJ, Hutchison DC. Alpha 1 antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 1983; 77:14-27.
17. Silverman EK, Miletich JP, Pierce JA, et al. Alpha-1 antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 1989; 140:961-966.
18. Stockley RA, Luisetti M, Miravitlles M, et al. Alpha one international registry (AIR) group. Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. Eur Respir J 2007; 29(3):582-586.
19. Strange C. Alpha-1 Foundation research registry: From the past to the future. J Pediatr Gastroenterol Nutr 2002; 34(1):1.
20. de Serres FJ, Blanco I, Fernandez-Bustillo E. PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Monaldi Arch Chest Dis 2007; 67:184-208.
21. Stoller JK, Aboussouan LS. Alpha-1 antitrypsin deficiency. Lancet 2005; 365:2225-2236.
22. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 1986; 89:370-373.
23. Taliercio R, Chatburn R, Stoller JK. Knowledge about alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: Results of a survey. Respir Care 2010; 55:322-327.
24. Rubenfeld GD, Cooper C, Carter G, Thompson BT, Hudson LD. Barriers to providing lung-protective ventilation to patients with acute lung injury. Crit Care Med 2004; 32(6):1289-1293.
25. Yu HT, Dylan ML, Lin J, Dubois RW. Hospital's compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007; 64(1):69-76.
26. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282:1458-1465.
27. Stoller JK, Fromer L, Brantly M, Stocks J, Strange C. Primary care diagnosis of alpha-1 antitrypsin deficiency: Issues and opportunities. Cleve Clin J Med 2007; 74:869-874.
28. Stoller JK. Emerging role of the respiratory therapist and the diagnosis of alpha-1 antitrypsin deficiency. AARC Times 2012; 36:11-13.
29. Stoller JK. Key current clinical issues in alpha-1 antitrypsin deficiency. Respir Care 2003; 48:1218-1224.
30. American Association for Respiratory Care. Emerging roles for the respiratory therapist in alpha-1 antitrypsin deficiency. http://www.aarc.org/ education/alpha1-course/. Accessed February 18, 2012.
31. Strange C, Moseley MA, Jones Y, et al. Genetic testing of minors for alpha-1 antitrypsin deficiency. Arch Pediatr Adolesc Med 2006; 160:531-534.
32. Alpha-1 Foundation Alpha-1 Coded Testing site. http://www.alpha- 1foundation.org/alphas/?c=02-Get-Tested. Accessed February 15, 2012.
33. Rahaghi F, Ortega I, Rahaghi N, et al. The impact of including physician alert accompanying pulmonary function (PFT) results on testing for detection of alpha-1 antitrypsin deficiency. J COPD 2009; 6:26-30.
34. Jain A, McCarthy K, Xu M, Stoller JK. Impact of clinical support system in an electronic health record to enhance detection of alpha-1 antitrypsin deficiency. Chest 2011; 140:198-204.
35. Alpha-1 Foundation schedule workshop on newborn screening for alpha-1 after genetic information nondiscrimination act takes effect. www.Alpha-1foundation.org/news/foundationsponsors- workshop-alpha-1-after- genetic-informationnondiscrimination- act-takes-effect. Accessed February 15, 1012.
36. Kallstrom T. American Association for Respiratory Care. Personal communication, Dallas, TX; October 2012.
37. Walsh JW, Snider GL, Stoller JK. A review of the Alpha-1 Foundation: Formation, impact, and critical success factors. Respir Care 2006; 51:526-531.
38. Brantly ML, Mishra VS, Viranovskaya N, Zienko L, Corcoran V, Leonard S, Schreck P, Adams H, Lundquist R, Pollock D. Statewide targeted screening and detection of AAT deficiency. Am J Respir Crit Care Med 2003; 167:A222.
39. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005 Mar; 352(10):969-977.
40. Love TE, Cebul RD, Einstadter D, et al. Electronic medical record-assisted design of a cluster-randomized trial to improve diabetes care and outcomes. J Gen Intern Med 2008 Apr; 23(4):383-391.
41. Campos M, Hagenlocker B, Martinez N, et al. Impact of an electronic medical record clinical reminder to improve detection of COPD and alpha-1 antitrypsin deficiency in the Veterans Administration (VA) system. Am J Respir Crit Care Med. 2011; 183:A5356.
42. Choudry SA, Choudy AB, Lee MD. Alpha-1 antitrypsin genotype screening in COPD patient identified by EMR. Am J Respir Crit Care 2011; 183:A5353.
43. Stoller JK (Chair), Snider GL (Rapporteur), et al. Alpha-1 antitrypsin deficiency: Memorandum from a WHO meeting. WHO Bull OMS 1997; 75:397-415.
44. O'Brien ML, Buist NRM, Murphey WH. Neonatal screening for alpha-1 antitrypsin deficiency. J Peds 1978; 92:1006- 1010.
45. Kaczor MP, Sanak M, Libura-Twardowska M, Szczeklik A. The prevalence of alpha-1 antitrypsin deficiency in a representative population sample from Poland. Respir Med 2007; 101:2520- 2525.
46. Kaczor MP, Sanak M, Szczeklik A. Rapid and inexpensive detection of alpha-1 antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a largescale population-based screening. J Mol Diagn 2007; 9:99-104.
47. Saris NE, Nyman MA, Varpela E, Nevanlinna HR. Serum alpha-1 antitrypsin mass concentrations in a Finnish young male population. Scand J Clin Lab Invest 1972; 29:249-252.
48. Sveger T, Mazodier P. Alpha-1 antitrypsin screening of 18-year-old men. Thorax 1979; 34:397-400.
49. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha-1 antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med 2002; 136:270-279.
50. Hoffmann JJ, van den Broek WG. Distribution of alpha-1 antitrypsin phenotypes in two Dutch population groups. Hum Genet 1976; 32:43-48.
51. Dijkman JH, Penders TJ, Kramps JA, Sonderkamp HJ, van den Broek WG, ter Haar BG. Epidemiology of alpha-1 antitrypsin deficiency in the Netherlands. Hum Genet 1980; 53:409-413.
52. Kimpen J, Bosmans E, Raus J. Neonatal screening for alpha-1 antitrypsin deficiency. Eur J Pediatr 1988; 148:86-88.
53. Cook PJ. The genetics of alpha-1 antitrypsin: a family study in England and Scotland. Ann Hum Genet 1975; 38:275-287.
54. Webb DR, Hyde RW, Schwartz RH, Hall WJ, Condemi JJ, Townes PL. Serum alpha-1 antitrypsin variants. Prevalence and clinical spirometry. Am Rev Respir Dis 1973; 108:918-925.
55. Lieberman J, Gaidulis L, Roberts L. Racial distribution of alpha-1 antitrypsin variants among junior high school students. Am Rev Respir Dis 1976; 114:1194-1198.
56. Evans HE, Bognacki NS, Perrott LM, Glass L. Prevalence of alpha-1 antitrypsin Pi types among newborn infants of different ethnic backgrounds. J Pediatr 1977; 90:621-624.
57. Morse JO, Lebowitz MD, Knudson RJ, Burrows B. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 1977; 296:1190-1194.
58. Dykes DD, Miller SA, Polesky HF. Distribution of alpha-1 antitrypsin variants in a US white population. Hum Hered 1984; 34:308-310.
59. Spence WC, Morris JE, Pass K, Murphy PD. Molecular confirmation of alpha-1 antitrypsin genotypes in newborn dried blood specimens. Biochem Med Metab Biol 1993; 50:233-240.
60. Klasen EC, D'Andrea F, Bernini LF. Phenotype and gene distribution of alpha-1 antitrypsin in a North Italian population. Hum Hered 1978; 28:474-478.
61. Corda L, Medicina D, La Piana GE, Bertella E, Moretti G, Bianchi L, Pinelli V, Savoldi G, Baiardi P, Facchetti F, Gatta N, Annesi-Maesano I, Balbi B. Population genetic screening for alpha-1 antitrypsin deficiency in a high-prevalence area. Respiration 2011; 82:418-425.
62. Goedde HW, Hirth L, Benkmann HG, Pellicer A, Pellicer T, Stahn M, Singh S. Population genetic studies of serum protein polymorphisms in four Spanish populations. II. Hum Hered 1973; 23:135-146.
63. Spinola C, Brehm A, Spinola H. Alpha-1 antitrypsin deficiency in the Cape Verde islands (Northwest Africa): High prevalence in a sub-Saharan population. Respir Med 2010; 104:1069- 1072.
64. Spinola C, Bruges-Armas J, Pereira C, Brehm A, Spinola H. Alpha-1 antitrypsin deficiency in Madeira (Portugal): The highest prevalence in the world. Respir Med 2009; 103:1498- 1502.
65. Vandeville D, Martin JP, Ropartz C. Alpha-1 antitrypsin polymorphism of a Bantu population: description of a new allele PiL. Humangenetik 1974; 21:33-38.
66. Massi G, Vecchio FM. Alpha-1 antitrypsin phenotypes in a group of newborn infants in Somalia. Hum Genet 1977; 38:265-269.
67. Aljarallah B, Ali A, Dowaidar M, Settin A. Prevalence of alpha-1 antitrypsin gene mutations in Saudi Arabia. Saudi J Gastroenterol 2011; 17:256-260.
68. Harada S, Miyake K, Suzuki H, Oda T. New phenotypes of serum alpha-1 antitrypsin in Japanese detected by gel slab isoelectric focusing. Hum Genet 1977; 38:333-336.
69. Wencker M, Marx A, Konietzko N, Schaefer B, Campbell EJ. Screening for alpha-1 Pi deficiency in patients with lung diseases. Eur Respir J 2002; 20:319-324.
70. Bals R, Koczulla R, Kotke V, Andress J, Blackert K, Vogelmeier C. Identification of individuals with alpha-1 antitrypsin deficiency by a targeted screening program. Respir Med 2007; 101:1708-1714.
71. de la Roza C, Rodriguez-Frias F, Lara B, Vidal R, Jardi R, Miravitlles M. Results of a case-detection programme for alpha-1 antitrypsin deficiency in COPD patients. Eur Respir J 2005; 26:616-622.
72. Corda L, Bertella E, Pini L, Pezzini A, Medicina D, Boni E, Guerini M, Trivella S, Grassi V, Tantucci C. Diagnostic flow chart for targeted detection of alpha-1 antitrypsin deficiency. Respir Med 2006; 100:463-470.
73. Luisetti M, Massi G, Massobrio M, Guarraci P, Menchicchi FM, Beccaria M, Balbi B. A national program for detection of alpha-1 antitrypsin deficiency in Italy. Gruppo I.D.A. Respir Med 1999; 93:169-172.
74. Matzen RN, Bader PI, Block WD. Alpha-1 antitrypsin deficiency in clinic patients. Ann Clin Res 1977; 9:88-92.